Sat.Sep 23, 2023 - Fri.Sep 29, 2023

article thumbnail

Do humans have a place in pharma’s AI future?

PharmaVoice

From COTA’s large datasets and AI model assistants to a company guiding patients through cancer care, AI can help — but it’s a long way from human-free.

265
265
article thumbnail

WHO recommends dropping component of many flu vaccines

STAT

The World Health Organization has recommended dropping a component of many flu vaccines because the viruses it protects against appear to have been driven into extinction in the Covid-19 pandemic. A family of viruses known as influenza B/Yamagata has not been seen since March 2020, when flu circulation worldwide declined to very low levels in the face of the onslaught of Covid and the protections people took to avoid contracting it.

Vaccines 364
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SAEM Clinical Images Series: Only a Flesh Wound

ALiEM - Pharm Pearls

A 49-year-old male was triaged to the Fast Track area with complaints of an abrasion to the neck following an assault. The patient was attending a party with his family when “someone started shooting.” The patient believes some stucco or stone fragment from a brick wall struck him in the neck during the initial incident, but his primary concern was for his more seriously wounded family members.

177
177
article thumbnail

AstraZeneca and SAS link up on AI and analytics

Pharma Times

Collaboration will enable teams across the organisation to increase clinical research innovation - News - PharmaTimes

154
154
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Elderly exclusion: Clinical trials still fall short enrolling older adults

PharmaVoice

Despite high rates of disease in older populations, systemic issues are keeping them out of research studies.

300
300
article thumbnail

STAT+: The Ozempic revolution is rooted in the work of Svetlana Mojsov, yet she’s been edged out of the story

STAT

On a mild May day in 1993, about 60 scientists and doctors gathered on a lawn in Copenhagen to commemorate the first International Symposium on GLP-1, the hormone that decades later would become the basis for highly effective diabetes and obesity drugs like Ozempic and Wegovy. The meeting was a scientific showcase of all the leading experts in the nascent field.

Hospitals 363

More Trending

article thumbnail

Women in Life Science Denmark launches leadership drive

Pharma Times

Initiative has been designed to support career advancement for women across the life sciences - News - PharmaTimes

146
146
article thumbnail

Inside Bavarian Nordic’s late-stage stumbles — and its drive to become a vaccine giant

PharmaVoice

Despite recent phase 3 setbacks in RSV and COVID-19, CEO Paul Chaplin sees a promising path forward in the travel vaccine market for the Dutch biotech.

Vaccines 246
article thumbnail

Rollout of Covid vaccines is bumpy, but not unexpected, experts say

STAT

The latest rollout of Covid-19 vaccines has been messy, with people facing more challenges getting one of the updated shots than they may have experienced since the frantic start of the very first vaccination campaign in late 2020 and the first half of 2021. The issues have come as a surprise to people whose appointments have been canceled for lack of vaccine doses, who couldn’t get an appointment at their nearest pharmacy, or who learned with dismay that the place where they got previous

Vaccines 363
article thumbnail

PulmCrit Hot Take: Aggressive glycemic control is dead (TGC-Fast Trial)

EMCrit Project

background Today the Van de Bergh group in Belgium released a RCT investigating tight versus liberal glycemic control in the ICU. Before diving into this study, let's take a walk down memory lane. Major interest in tight glycemic control in the ICU began in 2001 with an RCT by the same group of investigators, also […] EMCrit Project by Josh Farkas.

120
120
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

NICE nod for Darzalex with lenalidomide and dexamethasone

Pharma Times

Therapy has been developed to treat adult patients with newly diagnosed multiple myeloma - News - PharmaTimes

146
146
article thumbnail

Pfizer CEO Albert Bourla led Big Pharma bonus payouts over 5 years — but he’s no Elon Musk

PharmaVoice

A recent report showed how pharma’s bonuses pale in comparison to other industries, but several execs still rake in hefty packages.

Packaging 238
article thumbnail

Exodus of life scientists from academia reaches historic levels, new data show

STAT

New data released Thursday by the National Science Foundation show the exodus of young life scientists from the Ivory Tower to industry has reached the highest level in nearly three decades, deepening concerns about the future of academic science in the U.S. Among newly minted life science Ph.D.s in 2022 who had firm next steps, roughly 53% planned to pursue postdoctoral research, a temporary period of additional training that is virtually a requirement for those hoping to land a faculty job.

363
363
article thumbnail

Chemo-free regimen demonstrates efficacy in NSCLC

European Pharmaceutical Review

Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase III MARIPOSA study is the first to show a clinically meaningful benefit in a chemotherapy-free regimen compared to the small molecule treatment TAGRISSO ® ( osimertinib ). This is based on positive topline results for Rybrevant ® (amivantamab-vmjw) in combination with lazertinib, as first-line anti-cancer treatment in locally advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC).

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

NHS Confederation research supports investment in NHS services

Pharma Times

Report shows that if the health service invests in community services hospital admissions will reduce - News - PharmaTimes

Hospitals 132
article thumbnail

How pharma marketers can reclaim the drug pricing narrative

PharmaVoice

As Medicare negotiations heat up, it’s more important than ever for pharma companies to communicate their value. Here’s how.

article thumbnail

Gene therapy death was caused by an unknown risk of the virus used, study suggests

STAT

Last October, a 27-year-old man with Duchenne muscular dystrophy died after receiving a CRISPR-based treatment custom built to treat his particular genetic mutation. Results of a detailed investigation released on Wednesday suggest that the patient, Terry Horgan, likely died of a previously undocumented adverse effect of the virus used to deliver the CRISPR machinery to his cells.

363
363
article thumbnail

AI-supported spectroscopy delivers superior pharmaceutical packaging QC

European Pharmaceutical Review

A paper published in the IEEE Sensors Journal has demonstrated 100 percent inline pharmaceutical packaging content verification by combining standard diffuse reflectance MOEMS-EC-QCL spectroscopy with artificial intelligence (AI). It described how a quantum cascade laser (QCL)-based blister-verification sensor with verification via backscattering mid-infrared (IR) spectroscopy substance chemical identification can support blistering machines to achieve a better inline content verification.

Packaging 110
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Austrian State Secretary to speak at FlyPharma Europe 2023

Pharma Times

FlyPharma Europe is an event for the pharma logistics industry, connecting professionals from across the globe - News - PharmaTimes

125
125
article thumbnail

Former Novartis executive Tsai to lead UK heart drug startup

BioPharma Dive

John Tsai, previously Novartis’ chief medical officer, has been named CEO of Forcefield Therapeutics, an 18-month-old biotech working on a treatment for heart attacks.

110
110
article thumbnail

Did the government get a bad deal on the Covid-19 boosters?

STAT

WASHINGTON — After Pfizer and Moderna hiked the prices of their Covid-19 vaccines this year, the federal government will now pay nearly three times more than it did previously for each dose. And it’s paying more than countries that did far less to support vaccine development. Health and Human Services Secretary Xavier Becerra glossed over the dramatic increase in the amount the government is paying for vaccines in a public appearance last week, when he got vaccinated at a CVS pharm

Vaccines 364
article thumbnail

Lymphoma maintenance therapy delivers promise in CTCL

European Pharmaceutical Review

Resminostat (Kinselby) has been clinically proven to postpone disease progression, new data from one of the largest clinical trials in cutaneous T-cell lymphoma (CTCL) to date has revealed. The treatment is an oral small molecule class I, IIb and IV histone deacetylase (HDAC) inhibitor. Data from the RESMAIN resminostat study Findings from the RESMAIN study of the maintenance therapy could significantly change clinical practice in advanced CTCL, according to the company.

Labelling 110
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Seagen and Astellas announce results from EV-302 study

Pharma Times

Trial involves the use of Padcev and Keytruda among patients with certain types of urothelial cancer - News - PharmaTimes

129
129
article thumbnail

FDA staff hold ‘major concerns’ with Brainstorm ALS therapy, documents show

BioPharma Dive

Agency scientists flagged numerous issues with Brainstorm’s stem cell treatment ahead of a high-profile Wednesday meeting of expert FDA advisers.

article thumbnail

Women spend 20% more per year on out-of-pocket health costs, says report

STAT

Women of all ages pay a total of $15.4 billion more than men on annual out-of-pocket medical expenses, according to a new report from Deloitte. In 2021, that meant that women paid about 20% more than men — only 2% of which could be accounted for by maternity care. The fact that the way benefits are currently designed “puts a disproportionate cost on women, above and beyond maternity, was the thing that really surprised us,” said Kulleni Gebreyes, a physician who runs Deloitt

361
361
article thumbnail

CymaBay launches study into drug for liver scarring in patients with compensated cirrhosis

Outsourcing Pharma

A study to evaluate the effect of seladelparm, a small molecule treatment by CymaBay Therapeutics, Inc. on patients with cirrhosis was announced this month (September 21).

115
115
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

UKHSA reaches vaccine deal with CSL Seqirus

Pharma Times

Agreement will provide timely boost to pandemic preparedness against influenza - News - PharmaTimes

Vaccines 141
article thumbnail

Intercept, after biotech rollercoaster ride, agrees to buyout by Alfasigma

BioPharma Dive

Once valued at more than $7 billion, the liver drug company couldn’t secure a long-sought FDA approval in NASH and last month said it would abandon that research.

111
111
article thumbnail

STAT+: Biogen shutters digital health group, nixes Apple study, as part of cost cuts

STAT

Biogen, the iconic but embattled biotech firm, is shuttering Biogen Digital Health, its roughly 150-person group focused on using new types of data like those from mobile phones and smart watches, and ending a clinical trial being conducted with Apple early, STAT has learned. Biogen confirmed the organizational change, but said it might lean even more on digital tech startups in the future.

360
360
article thumbnail

Women in Science: ScaleReady’s Jenny Stjernberg and her fervent passion for cell and gene therapies

Outsourcing Pharma

At Advanced Therapies Europe 2023, BioPharma Reporter caught up with ScaleReady's Jenny Stjernberg to discuss her work at the biotech company, her journey from academia to commercial and female representation in the cell and gene therapies industry.

112
112
article thumbnail

Portsmouth NHS Trust maternity team enhances patient experience

Pharma Times

Patient waiting times to receive an appointment have reduced from 6-8 weeks to just 24 hours - News - PharmaTimes

132
132